APA (7th ed.) Citation

Simonelli, M., Rojas, C., Dziadziuszko, R., Park, J., Xue, J., Felip, E., . . . Sacher, A. (2025). 926MO MK-1084 monotherapy in participants (Pts) with KRAS G12C–mutated advanced solid tumors: Activity and safety in the phase I KANDLELIT-001 study. Annals of Oncology, 36, S606. https://doi.org/10.1016/j.annonc.2025.08.1495

Chicago Style (17th ed.) Citation

Simonelli, M., et al. "926MO MK-1084 Monotherapy in Participants (Pts) with KRAS G12C–mutated Advanced Solid Tumors: Activity and Safety in the Phase I KANDLELIT-001 Study." Annals of Oncology 36 (2025): S606. https://doi.org/10.1016/j.annonc.2025.08.1495.

MLA (9th ed.) Citation

Simonelli, M., et al. "926MO MK-1084 Monotherapy in Participants (Pts) with KRAS G12C–mutated Advanced Solid Tumors: Activity and Safety in the Phase I KANDLELIT-001 Study." Annals of Oncology, vol. 36, 2025, p. S606, https://doi.org/10.1016/j.annonc.2025.08.1495.